key: cord-0973304-l80l4v1m
authors: Musaoğlu, Mirac; Yuksel, Muhammed; Mizikoglu, Ozlem; Arikan, Cigdem
title: Telemedicine in monitoring pediatric LT patients before and during COVID‐19 pandemic
date: 2021-09-10
journal: Pediatr Transplant
DOI: 10.1111/petr.14138
sha: 4f65899a85e7b5f2118efd7edb5937a5f584ac65
doc_id: 973304
cord_uid: l80l4v1m

BACKGROUND: The delivery of healthcare services by telemedicine decreases costs of traveling for patients, is less time‐consuming, and most importantly permits the connection between highly skilled specialists and patients. However, whether the use of telemedicine (text messaging) for LT patients was affected by the COVID‐19 pandemic is unknown. METHODS: We collected data (following consent from patients and parents) from 57 patients (33 male/24 female) with a median age of 47 (IQR: 9–91) months, whom we followed up with text messaging between September 2019 and September 2020, spanning the 6 months prior to COVID‐19 and during this period. RESULTS: In total, 723 text message mediated consultations occurred during this period, henceforth simply referred to as “messages.” Three hundred and twenty‐eight (45%) messages occurred during the 6 months up to the start of the pandemic. Following the COVID‐19 outbreak, the number of messages increased to 395 (55%). The three most common reasons of messaging were post‐liver‐LT follow‐up messages (n = 215/723, 29.7%), consultations for drug use (n = 157/723, 21.7%), and medication prescriptions (n = 113/723, 15.6%). Protocol biopsy discussions (n = 33/723, 4.6%) and fever (n = 27/723, 3.7%) were among others (vaccination, rash, diarrhea, cough, fatigue, acne). During the COVID‐19 outbreak, only post‐LT follow‐up messages increased significantly to 132/395 (33%) from 83/328 (25%) (p‐value: .02). CONCLUSIONS: We found that the pandemic resulted in an increase in the total number of text message mediated consultations and specifically for the use of post‐LT follow‐up. Messaging was effective for post‐LT follow‐ups and all patients were at least satisfied.

surgeries. However, later on, COVID-19 and other diseases were managed in parallel. Yet, patients are reluctant to go to a hospital due to the high risk of infection.

The global outbreak caused by SARS-CoV-2 infection has challenged the healthcare system globally affecting (suspended or reduced) LT clinic visits and transplantations. [3] [4] [5] [6] The overwhelmed healthcare system has tried to replace in-person visits with telemedicine applications like video-conferencing, voice calls, and messages to prevent the spread of infection among patients and healthcare workers. 7, 8 This strategy of telehealth has also been applied in solidorgan transplantation clinics. 4, 5, [9] [10] [11] In a study done in Europe, 40% of the 18 pediatric transplantation centers had chosen to use telemedicine for outpatient visits during the pandemic. 4 In the United States, 61 of 83 solid-organ transplantation centers had changed their inperson visits to telemedicine visits due to COVID-19. 5 Another study reported the rise in the number of liver and intestinal transplantation centers implementing telemedicine, active in the United Network for Organ Sharing from February 2019 to April 2020. 9 There are several steps in LT in which telemedicine could be implemented in such as triage of patients, management of patients with chronic liver disease, post-transplantation care, and follow-ups of patients. 12 Although organ transplant patients are not considered as a confirmed high-risk population for the development of severe Coronavirus disease, 13 the healthcare providers 5 and immunosuppressed patients are afraid to attend in-person visits. 14 Therefore, telemedicine rises in popularity for post-transplantation care visits.

Firstly, this study aimed to explore whether the COVID-19 pandemic has changed the frequency of telemedicine (solely via text messages in this study) as it was already in place prior to the pandemic. Secondly, we investigated whether the use of telemedicine in a LT clinic has changed the post-transplantation care of patients owing to the COVID-19 pandemic. To clarify, the term telemedicine in our study refers only to consultations taking place via text messages. To that end, the words "text messages" or "text messaging" are employed to specifically denote this type of telemedicine to undertake the consultations.

At Koç University Hospital, telemedicine has been used for pediatric gastroenterology and LT patient clinic prior to the outbreak of the pandemic as the patient population is rather diverse with provenances reaching the far corners of the country and beyond. The clinic has been implementing telemedicine applications like video and voice calls or text messages for patients that could not come to the hospital, before the COVID-19 era. These applications were mostly offered to patients that reside in different cities and countries. The consultations have been carried out by mobile phone, either personal or assigned to the clinic, via text messages or calls.

The study was approved by Koç University Committee for Human Research (2020.381.IRB2.105). The signed informed consent forms were collected in two ways. The patients that visited the clinics or were hospitalized during the recruitment process of the study were given both a verbal explanation of the study and a written informed consent form. Other patients that did not have an appointment at the time of recruitment were reached and informed by phone call, and the consent form was sent by texting platforms and signed copies were returned likewise. In our clinic, a total of 264 patients are being followed for post-LT care. Out of the 264 patients, 156 (59%) patients were using telemedicine (phone call, video call, texts messages). All 156 patients provided consent and were included. Nighty-two patients opted to have a phone/video call as the main consultation method. Therefore, text messaging was rather an exception in this group. These patients were excluded because of a mixture of telemedicine (text and video call) used and because the personal phone of the physician was used in which conversations were not recorded. To that end, the total number of patients solely followed with text messages and had LT was 64 (24%). However, 7 patients were excluded due to the death (n = 4) of the patient during the time of the observation or records of the patients could not be achieved (n = 3) because the messages were erroneously deleted. The data on the use of text messaging was collected, from hard copy records of text message consultations, retrospectively starting from November 2, 2020. The text messages conveyed between September 13, 2019, and September 6, 2020, were analyzed and categorized into two groups for comparison. Eleven March was accepted as the first day of the COVID-19 period since the declaration of the pandemic and the first case in Turkey was reported on this day. The management plan for the complaints was also categorized into three groups as outpatient, inpatient, or telemedicine

The primary reason for LT was cholestatic liver disease followed by metabolic disorders and idiopathic hepatitis ( Table 1) Table 2 . There was also a trend of a decrease in the ratio of text messages for rhinorrhea, from 1.52% to 0.25%, and surgical site complications, from 2.74% to 1.01% (p = .09 for both).

The complaints of patients were mostly manageable without hospital admissions. Of all complaints, 77.2% (n = 558) were resolved by text messages. The resolution of the complaints by text messaging included digital prescriptions, advice on medication use, nutrition, vaccination schedule, and reassurance. The rate of cases resolved with text messaging was 81.0% (n = 320) during the pandemic, whereas this was only 72.5% (n = 238) before the pandemic, which was significantly different (p = .007). Thirteen percent (n = 94) of the cases required a visit to a healthcare center as an outpatient.

The ratio of referrals to an outpatient center was 14.6% (n = 48) in pre-pandemic era and 11.7% (n = 46) during the pandemic (p = .26).

Furthermore, the ratio of hospitalizations was 9.8% (n = 71) for the entire period. The ratio of hospitalization before the outbreak was 12.8% (n = 42), while it was 7.3% (n = 29%) (p = .02) in the course of the outbreak. When the type of resolution (by text messaging, inpatient or outpatient) was observed per reason of messaging, no changes were observed between the pre-and post-COVID-19 era (data not shown).

Furthermore, throughout the year we also queried how telemedicine was perceived by the patients/parents by two questions with 5-point Likert scale response values (Table 3 ). All 57 participants were at least satisfied, score 4 or 5, with text-messaging-mediated consultations.

Telemedicine or telehealth, used interchangeably, means delivery of health services with telecommunication. Telemedicine" is "healing at a distance." WHO has defined it as "the delivery of healthcare services, where distance is a critical factor. 15 An advantage of telemedicine is that it has been shown to decrease the costs of traveling for patients and is much less time-consuming. 16 Based on our survey, all participants and/or their parents (100%) were satisfied with text-messaging-mediated consultations and conveyed their satisfaction with the fact that all clinical needs were met by the physician through telemedicine. However, telemedicine in our clinic was an initiative taken by the physician long before the pandemic.

Hence, this was at the time not a hospital policy and there was no system to charge patients for the teleconsultations. In addition to the professional care, the free-of-charge consultations are likely an important reason why all patients perceived text messaging as at least satisfactory.

Prior to the pandemic, telemedicine was more frequently applied between peripheral primary healthcare providers and specialists located at specialized, academic institutions. Specialties currently using telemedicine are pediatric dermatology, psychiatry and surgery among others. 17, 18 Clinical data acquired at the primary institution can be readily examined by specialists. Although the accessibility of telemedicine was conceived to be limited by the lack of regulations and reluctance in replacing current practice, the new outbreak of COVID-19 likely will accelerate its acceptance by healthcare providers, as well as patients. 19 By making it more convenient for patients to obtain care, telemedicine has also increased access for those who might not otherwise be able to receive care or be seen at a practice. Before the COVID-19 pandemic, patients who may have benefited from telemedicine included those who cannot financially afford, elderly, or disabled patients or those who simply lived too far away to travel for an in-person visit. However, after this pandemic, it is conceivable that telemedicine will be used in a much broader patient population. In our cohort, even prior to the pandemic, the use of telemedicine (text/video call) was necessary to take care of patients living afar as specialized LT centers for pediatrics are rare. Following the pandemic, it permitted us not to lose contact with the patients. In this study, our findings Unequivocally, the pandemic changed the behavior of patients;

they are less-inclined to see a physician at a hospital. As this may not always be appropriate for the patient, it poses a financial burden for private-sector healthcare providers. Right up to the pandemic but also thereafter, telemedicine was merely controlled, not a standard hospital policy and foremost not charged by the institution. Now, telemedicine consultations via phone calls are logged in into the appointment system and patients are charged for this care. The future will demonstrate as to whether the frequency and or satisfaction of charged telemedicine will alter. Lastly, the language could be a barrier between care provider and receiver. By hospital policy, multilingual personnel is present to help when required. If not, there are interpreters who can assist;

however, this needs to be organized and is not free-of-charge.

In summary, this type of study might help in the establishment of novel and appropriate regulatory policies and investments in telemedicine applications as it benefits patients living remote to specialized healthcare providers, reducing (i) the necessity of traveling long distances and (ii) travel expenses. Equally, healthcare providers may benefit, as well as they can perform more consultations as they can see more patients but also because they can follow-up patients more

frequently. This may also create an alternative income source for the hospitals. However, telemedicine cannot replace current medical practice as physical examinations and interventions require the patient to be in a hospital.

All authors declare that there is no conflict of interest. 

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Cigdem Arikan https://orcid.org/0000-0002-0794-2741

Timeline: WHO's COVID-19 response

Turkish Republic Ministry of Health. REPUBLIC OF TURKEY MINISTRY COVID-19 INFORMATION PAGE

The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy

Pediatric transplantation in Europe during the COVID-19 pandemic: early impact on activity and healthcare

Early impact of COVID-19 on transplant center practices and policies in the United States

Organ procurement and transplantation during the COVID-19 pandemic

Virtually perfect? Telemedicine for Covid-19

Virtual health care in the era of COVID-19

In-person outreach and telemedicine in liver and intestinal transplant: a survey of national practices, impact of coronavirus disease 2019, and areas of opportunity

Telemedicine in the COVID-19 era for liver transplant recipients: an Italian lockdown area experience

Management of transplant patients outside hospital during COVID-19 epidemic: a Chinese experience

eHealth in transplantation

Low prevalence and disease severity of COVID-19 in post-liver transplant recipients-A single centre experience

Between fear and courage: attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic

Telemedicine-Opportunities and developments in member states

Patient satisfaction and healthcare utilization using telemedicine in liver transplant recipients

Section On Telehealth C. Telemedicine: pediatric applications

Telemedicine in pediatrics: possibilities and pitfalls

Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action?

Telemedicine in monitoring pediatric LT patients before and during COVID-19 pandemic